MB

Meghna Baid

Active Director Additional Director DIN 10786947
DIN 10786947 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Meghna Baid

Data last updated:

Meghna Baid is an Additional Director at Clb Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10786947
Primary Designation Additional Director
Industry Pharma
First Appointment 25 Sep 2024
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clb Pharmaceuticals Private Limited U24100TN2012PTC088472
Additional Director25 Sep 20242012Active

Board colleagues of Meghna Baid

NameDINCompanyDesignation
Narendra Kumar Baid06414420Clb Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clb Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Meghna Baid

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meghna Baid

Meghna Baid currently holds 1 directorship: Clb Pharmaceuticals Private Limited (Additional Director, since 25 Sep 2024).

Meghna Baid was first appointed on 25 Sep 2024 as Additional Director at Clb Pharmaceuticals Private Limited.

The current boards of Meghna Baid's companies include Narendra Kumar Baid (Clb Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available